In this study, we showed that FLT3‐ITD AML cells can be selectively inhibited by TCN‐PM, which exhibits a promising inhibition efficacy against FLT3‐ITD AML both in vitro and in vivo. Here, FLT3 is linked to acute myeloid leukemia.